These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19138292)

  • 1. Pharmacokinetics of cisplatin and methotrexate after M-VAC chemotherapy for advanced urothelial cancer in hemodialysis patients.
    Matsumoto K
    Int J Urol; 2008 Oct; 15(10):949-50. PubMed ID: 19138292
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience with combination chemotherapy consisting of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer].
    Nishio Y; Shirahase T; Shichiri Y; Habuchi T; Matsuda T; Nishimura K; Hida S; Okada Y; Yoshida O
    Hinyokika Kiyo; 1988 Aug; 34(8):1371-5. PubMed ID: 3195405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy for advanced urothelial cancer].
    Mikami K; Nakagawa S; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maegawa M; Nakao M
    Hinyokika Kiyo; 1994 Apr; 40(4):303-7. PubMed ID: 8191968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of cisplatin and methotrexate in a patient suffering from advanced ureteral tumor accompanied by chronic renal failure, undergoing combined hemodialysis and systemic M-VAC chemotherapy].
    Tokunaga J; Kikukawa H; Nishi K; Kitani K; Fujii J; Honda J; Wada Y; Ueda S; Nakano M
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2079-85. PubMed ID: 11103239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early clinical result of modified M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for advanced transitional cell carcinoma of renal pelvis and ureter].
    Shishido S; Hayakawa M; Higa I; Koyama Y; Hatano T; Osawa A
    Hinyokika Kiyo; 1990 Apr; 36(4):401-5. PubMed ID: 2378303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cisplatin-based chemotherapy in advanced urothelial tract cancer.
    Yagoda A
    Semin Oncol; 1989 Aug; 16(4 Suppl 6):98-104. PubMed ID: 2669142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Outcome of treatment with surgical resection of the remaining tumor after modified M-VAC treatment for advanced urothelial carcinoma].
    Narita S; Nakano M; Matsuzaki M; Watanabe J; Morikawa H; Murata H; Oda H; Komatsu H
    Hinyokika Kiyo; 2005 Mar; 51(3):155-8. PubMed ID: 15852667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium.
    Yamada Y; Itoh Y; Aoki S; Nakamura K; Taki T; Naruse K; Tobiume M; Zennami K; Katsuda R; Kato Y; Watanabe M; Nishikawa G; Minami M; Nakahira M; Ukai S; Sawada M; Kitamura A; Honda N
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1079-83. PubMed ID: 19277660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of right renal pelvic and ureter cancer with hepatic metastasis showing complete response by M-VAC].
    Sumiyoshi Y; Akiyama K; Yano M
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1521-3. PubMed ID: 2389946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of side effects caused by intra-arterial and intravenous infusion of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) for urothelial cancer].
    Uchida J; Okada H; Ohguchi N; Kawa G; Koyama Y; Mikami O; Kawamura H; Ohhara T; Matsuda T
    Hinyokika Kiyo; 1997 Sep; 43(9):637-40. PubMed ID: 9365842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy.
    Han KS; Joung JY; Kim TS; Jeong IG; Seo HK; Chung J; Lee KH
    Br J Cancer; 2008 Jan; 98(1):86-90. PubMed ID: 18087289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MEC treatment (methotrexate, etoposide, cisplatin) for urothelial cancer].
    Miura T; Murai T; Shimura H; Kondo I
    Gan To Kagaku Ryoho; 1992 May; 19(5):731-3. PubMed ID: 1580650
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pelvic lymph node metastasis from bladder cancer markedly responsive to methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy followed by radiotherapy: a case report].
    Hatano K; Kawashima A; Arai Y; Inoue H; Miyagawa Y; Takaha N; Nishimura K; Miyake O; Okuyama A
    Hinyokika Kiyo; 2006 Oct; 52(10):801-3. PubMed ID: 17131872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
    Saxman SB; Propert KJ; Einhorn LH; Crawford ED; Tannock I; Raghavan D; Loehrer PJ; Trump D
    J Clin Oncol; 1997 Jul; 15(7):2564-9. PubMed ID: 9215826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose-intensity MVAC for Advanced Renal Medullary Carcinoma: Report of Three Cases and Literature Review.
    Rathmell WK; Monk JP
    Urology; 2008 Sep; 72(3):659-63. PubMed ID: 18649931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal pelvic tumor in chronic renal failure: report of a case].
    Kojima Y; Uchida K; Takiuchi H; Wakatsuki A; Sakurai T; Ochi S; Shirai D; Kobayashi Y
    Hinyokika Kiyo; 1990 May; 36(5):587-91. PubMed ID: 2205088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide].
    Hashimoto H; Tokumitsu M; Morikawa M; Numata A; Yachiku S; Iuchi H; Yamauchi K
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):941-4. PubMed ID: 8678548
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma methotrexate concentrations in urothelial cancer chemotherapy].
    Kitamura Y; Watanabe M; Komatsubara S; Sakata Y
    Hinyokika Kiyo; 1990 Sep; 36(9):991-6. PubMed ID: 2239621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined therapy with 5-fluorouracil, doxorubicin, cis-diamminedichloroplatinum on advanced urothelial cancer].
    Kawai T; Washizuka M; Kihara K; Takahashi T; Sakata Y; Tai K; Nagayama T; Okada K; Kusuyama H; Ishii Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):40-6. PubMed ID: 3611890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.